project id: TCGA-ESCA; case submitter id: TCGA-Z6-A8JE; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.69; rna integrity number: 8.0; age at index: 57; days to birth: -20855; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1956; age at diagnosis: 20855; ajcc clinical m: M0; ajcc clinical n: N1; ajcc clinical stage: Stage IIIA; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 64.0; icd 10 code: C15.3; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper third of esophagus; synchronous malignancy: No; tissue or organ of origin: Upper third of esophagus; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 108; days to sample procurement: 0; initial weight: 150.0; portion submitter id: TCGA-Z6-A8JE-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 2.0; percent necrosis: 5.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;